Technology M&A Advisory

M&A Advisory

Lazard

Full Credential Description

Kinnate Biopharma. France, United States. Announced Date 01/03/2024. Deal value: $31m. Kinnate Biopharma Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre. Industry: Kinnate Biopharma is a biotechnology company focused on developing targeted therapies for cancer.

Back to Search Contact Business